twarde

DRUG4 trials

Sponsors

Medical University Of Lodz, Medical University Of Warsaw, Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy

Conditions

Attention-deficit hyperactivity disorderChildren primary nephropathy IgACrohn's diseaseMultiple sclerosisType 1 diabetes

Phase 2

LAMAinDiab - lisdexamphetamine vs methylphenidate for pediatric patients with ADHD and type 1 diabetes - a randomized crossover clinical trial.

Active, not recruitingCTIS2023-506862-30-00

Medical University Of LodzAttention-deficit hyperactivity disorder, Type 1 diabetes

Start: 2024-11-24Target: 150Updated: 2025-08-25

PRObiotic Therapy Examining Combinatorial Therapeutics in Multiple Sclerosis - phase II, multicenter, randomised, open-label clinical trial.

WithdrawnCTIS2025-520955-10-00

Wojskowy Instytut Medyczny Panstwowy Instytut BadawczyMultiple sclerosis

Target: 210Updated: 2025-10-20

Phase 3

Evaluation of the efficacy of topical treatment with budesonide in children with Crohn's disease located in the esophagus and/or stomach and/or duodenum - BETHESDa

RecruitingCTIS2024-519269-23-00

Medical University Of WarsawCrohn's disease

Start: 2024-03-27Target: 138Updated: 2025-07-10

SABINE - The efficacy and Safety of delayed-release Budesonide in children with primary IgA nephropathy - a multicenter, interventional phase III, randomized, placebo-controlled, double-blind study.

Not yet recruitingCTIS2024-518759-45-00

Medical University Of WarsawChildren primary nephropathy IgA

Target: 120Updated: 2025-11-25